Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Erbitux 100mg/20ml solution for infusion vials
0801050AGBBABAB
|
Erbitux | Cetuximab | Malignant Disease and Immunosuppression | No data available |
|
Erbitux 100mg/50ml solution for infusion vials
0801050AGBBAAAA
|
Erbitux | Cetuximab | Malignant Disease and Immunosuppression | No data available |
|
Erbitux 500mg/100ml solution for infusion vials
0801050AGBBACAC
|
Erbitux | Cetuximab | Malignant Disease and Immunosuppression | No data available |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.